Save your place

Sign in to WhoBought

Please try again later.

ANI Pharmaceuticals, Inc. (ANIP) institutional ownership

Latest close $77.72 Jul 20, 2026
Market cap$1.8B 52-week range SectorHealthcare
Funds holding · Q1 2026
275
reported ANIP position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Net bought $166M
147 buyers · 128 sellers

ANI Pharmaceuticals, Inc. (ANIP) price and institutional activity

Dates

Q1 2026

$382M bought by 147 investors
Goldentree Asset Management LP$52MUBS Group AG$27M +145 more
$216M sold by 128 investors
Global Alpha Capital Management Ltd.-$18MBalyasny Asset Management L.P.-$16M +126 more
Bought Sold Totals per quarter; hover a bar for the names.

ANI Pharmaceuticals, Inc. (ANIP) institutional activity · 275

Investor Type Est. change Change Δ Own Date
Goldentree Asset Management LP · New +$52M
Change +668K Date Q1 2026
Goldentree Asset Management LP New· Q1 2026 +$52M +668K Q1 2026
UBS Group AG · Added +$27M
Change +347K Date Q1 2026
UBS Group AG Added· Q1 2026 +$27M +347K Q1 2026
Soleus Capital Management, L.P. · Added +$26M
Change +334K Date Q1 2026
Soleus Capital Management, L.P. Added· Q1 2026 +$26M +334K Q1 2026
Jones Hill Capital LP · New +$25M
Change +319K Date Q1 2026
Jones Hill Capital LP New· Q1 2026 +$25M +319K Q1 2026
Global Alpha Capital Management Ltd. · Reduced −$18M
Change −229K Date Q1 2026
Global Alpha Capital Management Ltd. Reduced· Q1 2026 −$18M −229K Q1 2026
Tang Capital Management LLC · Added +$18M
Change +226K Date Q1 2026
Tang Capital Management LLC Added· Q1 2026 +$18M +226K Q1 2026
Balyasny Asset Management L.P. · Exited −$16M
Change −205K Δ Own −100.0% Date Q1 2026
Balyasny Asset Management L.P. Exited· Q1 2026 −$16M −205K −100.0% Q1 2026
Apis Capital Advisors, LLC · Exited −$15M
Change −196K Δ Own −100.0% Date Q1 2026
Apis Capital Advisors, LLC Exited· Q1 2026 −$15M −196K −100.0% Q1 2026
Goldman Sachs Group Inc · Reduced −$14M
Change −181K Date Q1 2026
Goldman Sachs Group Inc Reduced· Q1 2026 −$14M −181K Q1 2026
Sio Capital Management, LLC · Added +$14M
Change +178K Date Q1 2026
Sio Capital Management, LLC Added· Q1 2026 +$14M +178K Q1 2026
Ikarian Capital, LLC · New +$11M
Change +147K Date Q1 2026
Ikarian Capital, LLC New· Q1 2026 +$11M +147K Q1 2026
Parkman Healthcare Partners LLC · Added +$11M
Change +136K Date Q1 2026
Parkman Healthcare Partners LLC Added· Q1 2026 +$11M +136K Q1 2026
Invesco Ltd. · Added +$10M
Change +135K Δ Own +70.9% Date Q1 2026
Invesco Ltd. Added· Q1 2026 +$10M +135K +70.9% Q1 2026
American Century Companies Inc · Added +$10M
Change +133K Date Q1 2026
American Century Companies Inc Added· Q1 2026 +$10M +133K Q1 2026
BNP Paribas Financial Markets · Reduced −$10M
Change −130K Date Q1 2026
BNP Paribas Financial Markets Reduced· Q1 2026 −$10M −130K Q1 2026
Data through Q1 2026 · filed Jun 3, 2026
15 of 275

Famous investor activity in ANI Pharmaceuticals, Inc. (ANIP)

ANI Pharmaceuticals, Inc. (ANIP) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Cook Meredith · Officer Tax withholding or exercise payment (F) -$195K
Price $79.20 Qty -2K Owned 75K ΔOwn −3.2% Trade date Jul 18, 2026 Filed date Jul 21, 2026
Cook Meredith Officer Tax withholding or exercise payment (F) $79.20 -2K -$195K 75K −3.2% Jul 18, 2026 Jul 21, 2026
Cook Meredith · Officer Sell −$41K
Price $81.84 Qty −500 Owned 77K ΔOwn −0.6% Trade date Jul 13, 2026 Filed date Jul 14, 2026
Cook Meredith Officer Sell $81.84 −500 −$41K 77K −0.6% Jul 13, 2026 Jul 14, 2026
Carey Stephen P. · Officer Sell −$285K
Price $86.00 Qty −3K Owned 178K ΔOwn −1.8% Trade date Jul 2, 2026 Filed date Jul 6, 2026
Carey Stephen P. Officer Sell $86.00 −3K −$285K 178K −1.8% Jul 2, 2026 Jul 6, 2026
Carey Stephen P. · Officer 2 operations $0
Price $49.51 Qty 0 Owned 3K Trade date Jul 2, 2026 Filed date Jul 6, 2026
Carey Stephen P. Officer 2 operations $49.51 0 $0 3K Jul 2, 2026 Jul 6, 2026
Carey Stephen P. · Officer Sell −$240K
Price $84.12 Qty −3K Owned 178K ΔOwn −1.6% Trade date Jun 29, 2026 Filed date Jun 30, 2026
Carey Stephen P. Officer Sell $84.12 −3K −$240K 178K −1.6% Jun 29, 2026 Jun 30, 2026
Cook Meredith · Officer Sell −$41K
Price $82.03 Qty −500 Owned 78K Trade date Jun 12, 2026 Filed date Jun 15, 2026
Cook Meredith Officer Sell $82.03 −500 −$41K 78K Jun 12, 2026 Jun 15, 2026
Haughey Thomas · Director Sell −$162K
Price $80.88 Qty −2K Owned 39K Trade date Jun 8, 2026 Filed date Jun 10, 2026
Haughey Thomas Director Sell $80.88 −2K −$162K 39K Jun 8, 2026 Jun 10, 2026
Carey Stephen P. · Officer Sell −$265K
Price $80.00 Qty −3K Owned 180K Trade date Jun 5, 2026 Filed date Jun 9, 2026
Carey Stephen P. Officer Sell $80.00 −3K −$265K 180K Jun 5, 2026 Jun 9, 2026
Carey Stephen P. · Officer 2 operations $0
Price $49.51 Qty 0 Owned 7K Trade date Jun 5, 2026 Filed date Jun 9, 2026
Carey Stephen P. Officer 2 operations $49.51 0 $0 7K Jun 5, 2026 Jun 9, 2026
Thoma Jeanne · Director Grant (A) 4K
Owned 28K Trade date May 21, 2026 Filed date Jun 10, 2026
Thoma Jeanne Director Grant (A) 4K 28K May 21, 2026 Jun 10, 2026
Tannenbaum Renee P. · Director Grant (A) 4K
Owned 30K Trade date May 21, 2026 Filed date Jun 10, 2026
Tannenbaum Renee P. Director Grant (A) 4K 30K May 21, 2026 Jun 10, 2026
Pera Antonio R. · Director Grant (A) 4K
Owned 27K Trade date May 21, 2026 Filed date Jun 10, 2026
Pera Antonio R. Director Grant (A) 4K 27K May 21, 2026 Jun 10, 2026
Leonard Matthew J. · Director Grant (A) 4K
Owned 11K Trade date May 21, 2026 Filed date Jun 10, 2026
Leonard Matthew J. Director Grant (A) 4K 11K May 21, 2026 Jun 10, 2026
Haughey Thomas · Director Grant (A) 4K
Owned 41K Trade date May 21, 2026 Filed date Jun 10, 2026
Haughey Thomas Director Grant (A) 4K 41K May 21, 2026 Jun 10, 2026
Walsh Patrick D. · Director Sell −$806K
Price $80.63 Qty −10K Owned 38K Trade date May 13, 2026 Filed date May 13, 2026
Walsh Patrick D. Director Sell $80.63 −10K −$806K 38K May 13, 2026 May 13, 2026
15 of 116
15 of 116 Sign in to continue to older insider transactions.

ANI Pharmaceuticals, Inc. (ANIP) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
BlackRock Inc. 2.5M
% of shares outstanding 12.4% Filing date Jan 23, 2024
BlackRock Inc. 2.5M 12.4% Jan 23, 2024
Meridian Venture Partners II Gp, L.P. 1.4M
% of shares outstanding 6.7% Filing date Mar 14, 2024
Meridian Venture Partners II Gp, L.P. 1.4M 6.7% Mar 14, 2024
Vanguard Group Inc 1.3M
% of shares outstanding 6.3% Filing date Feb 13, 2024
Vanguard Group Inc 1.3M 6.3% Feb 13, 2024
Esjay LLC 933K
% of shares outstanding 4.6% Filing date Jan 17, 2024
Esjay LLC 933K 4.6% Jan 17, 2024
Rubric Capital Management LP 57K
% of shares outstanding 0.3% Filing date Nov 13, 2024
Rubric Capital Management LP 57K 0.3% Nov 13, 2024
5 of 5

ANI Pharmaceuticals, Inc. (ANIP) ownership FAQ

Who owns ANIP?

275 reporting institutions disclosed ANIP position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.